The market is once again favoring so-called high-beta stocks, those with bigger-than-average price swings. Investors might do ...

Orange stock remains a strong Buy post a 55% YTD rally, with upside from rate cuts, a strategic plan, and gains from the ...

Is Google the most undervalued AI play in the stock market right now? Here's what key indicators are saying ahead of Wednesday night's earnings.

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

Wondering where to find value in a red-hot tech sector? Check out these overlooked tech gems while they're still cheap.

Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.

As small and midcap funds begin to lose their momentum, discover how value funds are stepping into the spotlight.

Highlighted opportunities include NANO Nuclear Energy's niche potential, Christian Dior SE's LVMH exposure, and Harrow's ...

Explore potentially undervalued stocks identified by an analyst, including Palantir, Salesforce, and others. Plus, get an ...

Morgans has an add rating and $3.30 price target on Regal Partners' shares. A third ASX stock to have been given a buy rating ...

As the U.S. stock market navigates a turbulent landscape marked by political tensions and mixed economic signals, investors are keeping a close eye on potential opportunities amid volatility. In such ...

Fewer IPOs and a booming private market mean ordinary investors have less access to fast-growing companies. Here's how that ...